Nadia Nasser

458 total citations
9 papers, 366 citations indexed

About

Nadia Nasser is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Nadia Nasser has authored 9 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Sensory Systems, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Nadia Nasser's work include Ion Channels and Receptors (8 papers), Biochemical Analysis and Sensing Techniques (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). Nadia Nasser is often cited by papers focused on Ion Channels and Receptors (8 papers), Biochemical Analysis and Sensing Techniques (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). Nadia Nasser collaborates with scholars based in United States, Denmark and Israel. Nadia Nasser's co-authors include Adrienne E. Dubin, Sandra R. Chaplan, J. Guy Breitenbucher, Scott L. Dax, Alan D. Wickenden, Michael P. Maher, Hong Ao, Devin M. Swanson, Sui‐Po Zhang and Ellen E. Codd and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Nadia Nasser

9 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Nasser United States 8 216 122 78 66 57 9 366
Richard Tran United States 10 227 1.1× 119 1.0× 100 1.3× 39 0.6× 66 1.2× 15 326
Lauri Moilanen Finland 10 224 1.0× 94 0.8× 108 1.4× 49 0.7× 85 1.5× 19 490
Carolina García‐Martínez Spain 9 308 1.4× 153 1.3× 210 2.7× 50 0.8× 133 2.3× 9 487
Neelima Khairatkar-Joshi India 11 268 1.2× 113 0.9× 210 2.7× 60 0.9× 62 1.1× 21 586
Nathaniel Wallace United States 11 99 0.5× 84 0.7× 119 1.5× 35 0.5× 66 1.2× 15 483
Pamela Pedretti Italy 5 426 2.0× 305 2.5× 118 1.5× 88 1.3× 113 2.0× 6 696
Piotr K. Zakrzewski Poland 13 70 0.3× 124 1.0× 156 2.0× 31 0.5× 85 1.5× 21 484
Pau Doñate‐Macian Spain 8 221 1.0× 66 0.5× 130 1.7× 23 0.3× 42 0.7× 9 346
Sahar M. Jaffal Jordan 11 58 0.3× 75 0.6× 96 1.2× 20 0.3× 24 0.4× 31 322
Guosen Ye United States 5 174 0.8× 70 0.6× 86 1.1× 16 0.2× 16 0.3× 7 307

Countries citing papers authored by Nadia Nasser

Since Specialization
Citations

This map shows the geographic impact of Nadia Nasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Nasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Nasser more than expected).

Fields of papers citing papers by Nadia Nasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Nasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Nasser. The network helps show where Nadia Nasser may publish in the future.

Co-authorship network of co-authors of Nadia Nasser

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Nasser. A scholar is included among the top collaborators of Nadia Nasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Nasser. Nadia Nasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McNally, James J., Mark A. Youngman, Mark E. McDonnell, et al.. (2008). N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1). Bioorganic & Medicinal Chemistry Letters. 18(8). 2730–2734. 4 indexed citations
2.
Maher, Michael P., Hong Ao, Tue G. Banke, et al.. (2008). Activation of TRPA1 by Farnesyl Thiosalicylic Acid. Molecular Pharmacology. 73(4). 1225–1234. 53 indexed citations
3.
Lebsack, Alec D., Michael D. Hack, Wei Xiao, et al.. (2008). Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 40–46. 18 indexed citations
4.
Bhattacharya, Anindya, Brian Scott, Nadia Nasser, et al.. (2007). Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 323(2). 665–674. 62 indexed citations
5.
Youngman, Mark A., James J. McNally, Mark E. McDonnell, et al.. (2007). Heteroaryl β-tetralin ureas as novel antagonists of human TRPV1. Bioorganic & Medicinal Chemistry Letters. 17(22). 6160–6163. 18 indexed citations
6.
Dubin, Adrienne E., Nadia Nasser, An N. Hermans, et al.. (2005). Identifying Modulators of hERG Channel Activity Using the PatchXpress® Planar Patch Clamp. SLAS DISCOVERY. 10(2). 168–181. 33 indexed citations
7.
Youngman, Mark A., James J. McNally, Sui‐Po Zhang, et al.. (2004). N-Isoquinolin-5-yl-N′-aralkyl-urea and -amide antagonists of human vanilloid receptor 1. Bioorganic & Medicinal Chemistry Letters. 14(12). 3053–3056. 18 indexed citations
8.
Swanson, Devin M., Adrienne E. Dubin, Chandra Shah, et al.. (2004). Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist. Journal of Medicinal Chemistry. 48(6). 1857–1872. 144 indexed citations
9.
McDonnell, Mark E., et al.. (2003). 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1. Bioorganic & Medicinal Chemistry Letters. 14(2). 531–534. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Tran Breakdown of academic impact, for papers by Lauri Moilanen Breakdown of academic impact, for papers by Carolina García‐Martínez Breakdown of academic impact, for papers by Neelima Khairatkar-Joshi Breakdown of academic impact, for papers by Nathaniel Wallace Breakdown of academic impact, for papers by Pamela Pedretti Breakdown of academic impact, for papers by Piotr K. Zakrzewski Breakdown of academic impact, for papers by Pau Doñate‐Macian Breakdown of academic impact, for papers by Sahar M. Jaffal Breakdown of academic impact, for papers by Guosen Ye
Rankless by CCL
2026